Rockwell Automation Announces Senior Leadership Transition
1.10.2019 16:01:00 EEST | Business Wire | Press release
Rockwell Automation Inc. (NYSE: ROK) announces senior leadership transition to be effective November 1, reporting to Blake Moret, Chairman, and CEO.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191001005364/en/
Ernest Nicolas, currently vice president, global supply chain, is promoted to senior vice president, Operations & Engineering Services, reporting to Blake Moret, Chairman, and CEO. (Photo: Business Wire)
Ernest Nicolas, currently vice president, global supply chain, is promoted to senior vice president, Operations & Engineering Services. He will have global leadership accountability for the six functions in OES that include, Global Supply Chain (Strategic Sourcing, Materials, Logistics, and Customer Care), Quality & Continuous Improvement, Engineering Services, Manufacturing Operations, Manufacturing Services, and Workplace Services. Nicolas will lead more than 9,500 OES employees and contractors and 19 manufacturing plants globally.
Mike Laszkiewicz, senior vice president, Operations & Engineering Services, announced his intent to retire effective January 31, 2020. He will continue to report to Moret until his retirement and will work to ensure a successful transition. “I appreciate Mike’s continued service to ensure smooth leadership transitions in the coming months,” said Moret. “Mike has held many leadership roles through his thirty-year career, notably leading the Power Control Business in CP&S before his senior leadership role in OES. His counsel to me has been tremendously valuable.”
“Ernest is precisely the kind of leader I want to accelerate our growth. Ernest brings a wealth of manufacturing and supply chain leadership experience, and a passion for people, with genuine care for team success,” said Moret. “I value his thoughtful and strategic counsel.”
Nicolas joined Rockwell Automation in 2006 as a Lean, Six Sigma Project Manager and has held several roles within the Operations & Engineering Services (OES) functions, including vice president, Global Supply Chain and vice president Strategic Sourcing and Supply Management, director Asia Pacific Manufacturing Operations and plant manager Twinsburg Operations.
Before Rockwell Automation, Nicolas spent 9 years in various roles of increasing responsibility at General Motors Corporation. He is a member of the Executive Leadership Council (ELC), the advisory board for the Grainger Center of Supply Chain Management at the University of Wisconsin-Madison and on the board of directors for the Milwaukee Urban League.
Nicolas holds a Master of Business Administration (M.B.A.) in Operations Management from the University of Wisconsin-Madison, Master of Science (M.S.) in Manufacturing Systems Engineering from the University of Wisconsin-Madison, and a Bachelor of Science (B.S.) in Manufacturing Systems Engineering from Kettering University.
About Rockwell Automation
Rockwell Automation Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and information, makes its customers more productive and the world more sustainable. Headquartered in Milwaukee, Wis., Rockwell Automation employs approximately 23,000 people serving customers in more than 80 countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191001005364/en/
Contact information
Ike Theodore Umunnah
Director, Global Public Affairs
1-414-382-5679
itumunna@ra.rockwell.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 17:50:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive
emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 18:12:00 EEST | Press release
emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead
Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 16:00:00 EEST | Press release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme
EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 16:00:00 EEST | Press release
European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 15:00:00 EEST | Press release
ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom